TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,218.00▼ 7.87%TCS₹2,100.00▼ 8.85%HDFCBANK₹711.45▼ 0.09%ICICIBANK₹1,342.80▼ 5.65%INFY₹1,013.85▼ 10.28%HINDUNILVR₹1,895.20▼ 3.96%ITC₹266.70▲ 0.98%SBIN₹958.75▼ 5.64%BHARTIARTL₹1,810.50▼ 1.60%KOTAKBANK₹431.90▲ 1.74%LT₹3,770.00▼ 4.90%AXISBANK₹1,248.00▼ 1.96%ASIANPAINT₹2,424.20▼ 4.08%MARUTI₹11,625.00▼ 8.42%AAPL$333.63▲ 4.27%MSFT$529.30▲ 5.92%GOOGL$347.68▲ 2.72%AMZN$256.29▼ 0.86%NVDA$239.24▲ 3.85%META$738.88▲ 19.80%TSLA$380.68▲ 7.51%BRK-B$505.54▼ 0.10%JPM$331.28▼ 7.63%V$370.64▼ 1.18%
RELIANCE₹1,218.00▼ 7.87%TCS₹2,100.00▼ 8.85%HDFCBANK₹711.45▼ 0.09%ICICIBANK₹1,342.80▼ 5.65%INFY₹1,013.85▼ 10.28%HINDUNILVR₹1,895.20▼ 3.96%ITC₹266.70▲ 0.98%SBIN₹958.75▼ 5.64%BHARTIARTL₹1,810.50▼ 1.60%KOTAKBANK₹431.90▲ 1.74%LT₹3,770.00▼ 4.90%AXISBANK₹1,248.00▼ 1.96%ASIANPAINT₹2,424.20▼ 4.08%MARUTI₹11,625.00▼ 8.42%AAPL$333.63▲ 4.27%MSFT$529.30▲ 5.92%GOOGL$347.68▲ 2.72%AMZN$256.29▼ 0.86%NVDA$239.24▲ 3.85%META$738.88▲ 19.80%TSLA$380.68▲ 7.51%BRK-B$505.54▼ 0.10%JPM$331.28▼ 7.63%V$370.64▼ 1.18%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸ABT

Abbott Laboratories Common Stock

NYSE
$98.16
▼ $10.17 (-9.4%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 06 Oct 2026
H $117.34L $81.97-3.7%
$117.34$110.27$103.19$96.12$89.04$81.97$98.16
RSI (14)
Intraday · 15-minSell-30RSI 27DowntrendMACD Bearishfor day-trading context — not advice

Technical signal

Strong sell-60
RSI (14)36
oversold 30overbought 70
Trend
Downtrend
MACD
Bearish
Bollinger
Within bands
vs 20-day
below
vs 50-day
below
vs 200-day
below
Support
$95.06
Resistance
$106.86
  • Price is below its 50-day average (medium-term weakness).

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

Signal backtest · 2026-01-02 → 2026-10-06

Strategy return
+13.3%
Buy & hold
-21.0%
Trades
3
Win rate
33%

$100,000.00 invested would be worth $113,298.52 (+13.3%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Abbott Laboratories· Medical Devices

source: yahoo

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Sector
Healthcare
Industry
Medical Devices
Employees
122,000
Headquarters

Fundamentals

source: yahoo
Market cap
$169.85B
P/E
32.3
P/B
3.3
EPS
$3.04
Div yield
2.5%
Profit margin
11.6%
ROE
10.6%
Debt / Equity
0.63
Beta
0.58
52-week range
$81.97 – $135.13
52-week low · $81.9730% of rangehigh · $135.13

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:▲ Positive3↑ · 0↓ · 5–
  • Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note— Neutral
    Zacks · 06 Oct 2026
  • Better Dividend Play for Retirees: MDT or ABT? One Delivers Significantly More Yield▲ Positive
    24/7 Wall St. · 06 Oct 2026
  • Amex GBT Announces Planned CEO Transition— Neutral
    Business Wire · 06 Oct 2026
  • These 5 Dividend Kings Raised Their Payouts The Most Over The Last Year
Abbott Park, United States
www.abbott.com ↗
▲ Positive
24/7 Wall St. · 06 Oct 2026
  • AbbVie Rewarded Patient Investors but Punished Those Who Bought on Good News— Neutral
    24/7 Wall St. · 06 Oct 2026
  • If The MiniMed Split-Off Stalls, What Happens To Your Medtronic Stock?— Neutral
    Trefis · 06 Oct 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.